3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
12
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Melanoma
13
Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Locally Advanced Melanoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Eunuchism
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Interventions
Blood Specimen Collection
6
Radiotherapy
2
Quality of Life
2
Phlebotomy
2
Interviews as Topic
2
Drug Therapy
2
zolbetuximab
1
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
iopromide
1
capecitabine-irinotecan combination
1
X-Rays
1
Tumor Burden
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Risedronic Acid
1
Registries
1
Raloxifene Hydrochloride
1
Radiofrequency Ablation
1
Radiation, Ionizing
1
Radiation
1
Positron-Emission Tomography
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Ipilimumab
1
Induction Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Adenocarcinoma
×
Nivolumab
×
Clear all
NCT06504615
2026-04-03
METAGIO
Bristol-Myers Squibb
Active not recruiting
208 enrolled